Opinion
Video
Recent Medical Advancements: Opportunities and Considerations
Author(s):
An expert discusses the extended form of carbidopa/levodopa (Crexont) for managing OFF episodes, highlighting trial results that show decreased OFF time and increased ON time, as well as the use of subcutaneous loading of medications in Parkinson disease, which was well tolerated with skin issues as the main adverse effects and resulted in increased ON time without worsening dyskinesia.
Video Player is loading.
Related Videos
Second-Line Treatments for CIDP
Evaluating Efficacy and Individualizing Treatment in CIDP
The Critical Role of Dystrophin in the Pathophysiology of Duchenne Muscular Dystrophy
Navigating Duchenne Muscular Dystrophy: An Early-Childhood Case Example
CSAI and INFUS-ON Study for Treatment of Parkinson Disease
Continuous Subcutaneous Apomorphine Infusion (CSAI) and TOLEDO Study in Parkinson Disease
Insights on Quanterix Simoa Assay to Diagnose Alzheimer Disease: Mark Roskey, PhD
Video: Dyskinesia and Patient Communication in Parkinson Disease
Continuous Dosing of Lecanemab for Alzheimer’s Disease
Clarity-AD-OLE Study in Alzheimer’s Disease
Related Content
